PHARMACYTE BIOTECH, INC. Marketable Securities (Current)
PHARMACYTE BIOTECH, INC. (PMCB) had Marketable Securities (Current) of $99.46 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-09-14
- 2026-07-31: Marketable Securities, Current $99.46K.
- 2026-04-30: Marketable Securities, Current $254.01K.
- 2026-01-31: Marketable Securities, Current $372.25K.
- 2025-10-31: Marketable Securities, Current $201.19K.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-07-31 | $99.46K 10-Q · filed 2026-09-14 |
| 2026-04-30 | $254.01K 10-Q · filed 2026-09-14 |
| 2026-01-31 | $372.25K 10-Q · filed 2026-03-17 |
| 2025-10-31 | $201.19K 10-Q · filed 2025-12-18 |
| 2025-07-31 | $261.85K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $366.32K 10-K · filed 2026-07-29 |
| 2025-01-31 | $372.63K 10-Q · filed 2025-03-17 |
| 2024-04-30 | $0.00 10-K · filed 2025-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |